Phage therapy program
Former PhagoMed / BioNTech R&D Austria
| Status | Historical/inactive |
|---|---|
| Type | Company |
| Location | Vienna; Austria |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Former independent company was acquired by BioNTech in 2021; no current independent patient access route established. |
|---|---|
| Areas of work | Synthetic lysin antibacterial development; not established as a current live-phage clinic. |
| International access | No current human treatment referral policy established. |
What to confirm
- Historical/inactive applies to the independent PhagoMed entity, not a claim that BioNTech Austria has ceased all R&D.
- Present antibacterial pipeline continuation was not established.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | eu-phagomed-biontech |
|---|